Albemarle Corp (ALB)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $11.04B
Last updated: Nov 17, 2026 at 11:05 AM ET
Albemarle Corp (ALB) Stock Forecast
Analysts expect Albemarle (ALB) to earn $10.51 per share in the fiscal year ending Dec 31, 2026, on revenue of $6.03B. Of 23 analysts, 14 rate the stock Buy or Strong Buy, 9 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $8.46.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 23 ratings average 2.30, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 61% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 8.7% |
| Buy | 12 | 52.2% |
| Hold | 9 | 39.1% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 23
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 19.5% and revenue estimates fall 2.8%.
- Fiscal year ending Dec 31, 2026
- $10.51
- EPS consensus, revenue $6.03B
- Fiscal year ending Dec 31, 2027
- $8.46
- EPS consensus, revenue $5.86B
- Next report
- Feb 9, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $10.51 | $9.32 to $11.28 | 16 | $6.03B | $5.68B to $6.32B | 18 |
| Dec 31, 2027 | $8.46 | $3.74 to $12.65 | 18 | $5.86B | $4.68B to $8.15B | 18 |
Quarterly Estimates
The EPS consensus rises from $1.31 for the quarter ending Dec 31, 2026 to $1.55 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.31 | $0.04 to $2.11 | 18 | $1.39B | $1.22B to $1.67B | 15 |
| Mar 31, 2027 | $1.55 | $0.16 to $2.69 | 5 | $1.37B | $1.23B to $1.51B | 4 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 5 upward and 6 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2027 | 4 | 5 |
| Quarter ending Mar 31, 2027 | 1 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 8.8% from $11.52.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $10.51 | $11.08 | $11.43 | $11.57 | $11.52 | -8.7% |
| Fiscal year ending Dec 31, 2027 | $8.46 | $10.44 | $10.97 | $11.30 | $11.52 | -26.6% |
| Quarter ending Mar 31, 2027 | $1.55 | $2.49 | $1.87 | $2.06 | $2.06 | -24.6% |
Frequently Asked Questions About ALB
What is the ALB stock forecast?
Consensus analyst estimates put Albemarle's EPS at $10.51 for the fiscal year ending Dec 31, 2026, on revenue of $6.03B. The consensus rating from 23 analysts is Buy.
How do analysts rate ALB stock?
Of 23 analysts covering Albemarle, 2 rate it Strong Buy, 12 Buy, 9 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from ALB next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $10.51, with estimates from $9.32 to $11.28 from 16 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $8.46, with estimates from $3.74 to $12.65 from 18 analysts.
What revenue do analysts expect from Albemarle next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $6.03B, with estimates from $5.68B to $6.32B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $5.86B, with estimates from $4.68B to $8.15B.
How many analysts cover ALB?
23 analysts rate Albemarle stock, and 16 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
ALB pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts